Health insurers are crying foul after a study funded by an insurance trade group found that Medicare Advantage, the private insurance version of Medicare, does not receive nearly the money it should get from the federal government for patients with chronic conditions.
Specifically, the study by Avalere, a health care consulting firm, found that the Centers for Medicare and Medicaid Services (CMS) underestimates the cost it takes to treat seniors with common conditions, such as arthritis and depression.
"We find that the model under-predicts expenditures for chronic non-cancer pain ($14.3 billion), osteoarthritis ($13.4 billion), depression ($8.9 billion), and [Rheumatoid Arthritis] ($5.3 billion)," the report concludes.
Complete your profile to continue reading and get FREE access to BenefitsPRO, part of your ALM digital membership.
Your access to unlimited BenefitsPRO content isn’t changing.
Once you are an ALM digital member, you’ll receive:
- Breaking benefits news and analysis, on-site and via our newsletters and custom alerts
- Educational webcasts, white papers, and ebooks from industry thought leaders
- Critical converage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
Already have an account? Sign In Now
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
